Royal Bank of Canada’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-145
Closed 7658
2024
Q2
$0 Buy
+145
New +$299 ﹤0.01% 7682
2024
Q1
Sell
-97
Closed -$1K 7749
2023
Q4
$1K Buy
+97
New +$511 ﹤0.01% 7021
2023
Q3
Sell
-100
Closed 7746
2023
Q2
$0 Buy
+100
New +$346 ﹤0.01% 7774
2022
Q4
Sell
-192
Closed 7865
2022
Q3
$0 Buy
+192
New +$329 ﹤0.01% 7993

Other funds holding AUGX

Royal Bank of Canada's AUGX Position: Q3 2024 in Review

Royal Bank of Canada sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 145 shares.

Royal Bank of Canada first reported a position in AUGX in Q3 2022 and held it in 4 quarters. The position peaked at $1K in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Royal Bank of Canada reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 145 Augmedix, Inc. Common Stock shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Augmedix, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Royal Bank of Canada's Augmedix, Inc. Common Stock position peaked at $1K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.